M T Lotze

University of Pittsburgh — United States

Immunology and Microbiology · Life Sciences

33h-index5.4kcitations81works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(28), Cancer Immunotherapy and Biomarkers(20), Immune Cell Function and Interaction(17), CAR-T cell therapy research(13), Monoclonal and Polyclonal Antibodies Research(10)

Publications81 total

Pancreatic cancer organoids recapitulate chemotherapy response and identify potent T cell subsets
HPB·2024Open Access
Pancreatic cancer organoids recapitulate chemotherapy response and identify potent T cell subsets
HPB·2024Open Access
The systemic immune-inflammation index (SII) predicts neoadjuvant therapy response and survival in patients with pancreatic cancer who are CA 19-9 non-secretors
HPB·2021Open Access
Phenotypic and functional characterization of tumor infiltrating lymphocytes (TIL) grown from non-hodgkin lymphoma tumors: Implications for the development of novel therapies for lymphoma
Annals of Oncology·2017· 1 cited
The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer
Cancer Gene Therapy·2015· 166 citedOpen Access
A first-in-human phase I study of intravenous PI3K inhibitor BAY 80-6946 in patients with advanced solid tumors: Results of dose-escalation phase.
Journal of Clinical Oncology·2011· 31 cited
Expression and Effects of IL-33 and Its Receptor in a Murine Pancreatic Cell Line
Journal of Surgical Research·2010
Diffusion Tensor Bildgebung des neurologisch intakten humanen Myelon in vivo
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren·2009
MECHANISTIC INSIGHTS: LONG-TERM ALLOGRAFT SURVIVAL BY ADMINISTRATION OF IMMATURE DENDRITIC CELLS AND SUBDOSING SIROLIMUS
Transplantation·2004
HMGBI AND TUMOR IMMUNOLOGY
Shock·2004
Phase II trial of interleukin 2, interferon α, and 5-fluorouracil in metastatic renal cell cancer
Urologic Oncology Seminars and Original Investigations·2002
Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
PubMed·2001· 130 cited
CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
PubMed·2000· 150 cited
Gene Transfection Using Particle Bombardment
Gene Therapy·1999
Effective gene therapy for liver tumors with intra-arterial injection of IL-12 gene-engineered fibroblasts (Preliminary study)
1998
A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer.
PubMed·1998· 23 cited
Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects.
PubMed·1998· 38 cited
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
PubMed·1998· 178 cited
Prevalence of infection with <i>Cryptosporidium parvum</i> and <i>Cyclospora cayetanensis</i> among international travellers
Gut·1997· 64 citedOpen Access
CULTURE ON HUMAN DENDRITIC CELLS (DC) FOR THERAPY OF PATIENTS WITH CANCER
Journal of Immunotherapy·1997
page 1 of 5Next →

Frequent Co-authors

Walter J. Storkus(11), Markus Maeurer(6), Steven A. Rosenberg(6), S A Rosenberg(5), Laurence Zitvogel(4), Paul D. Robbins(3), Hideaki Tahara(3), Maury Rosenstein(3), Jorge A. Carrasquillo(3), José Mayordomo(2), Christina M. Celluzzi(2), Louis D. Falo(2), Susanne M. Gollin(2), D Martin(2), William Swaney(2), Chiara Castelli(2), John M. Kirkwood(2), John L. Strausser(2), H Stötter(2), Eric S. Groves(2)